SCHEMBL9865765

SCHEMBL9865765

O=C(NC(=NCCCc1c[nH]cn1)NCCSc1ccccn1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 3/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
TP53 P04637 1/20 0.45
HPGD P15428 1/20 0.42
LMNA P02545 2/20 0.41
ALDH1A1 P00352 4/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
HRH4 Q9H3N8 5/20 0.39
HRH2 P25021 4/20 0.39
L3MBTL1 Q9Y468 1/20 0.37
HRH1 P35367 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9866479 0.96 RAB9A (0.42) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL9866473 0.94 RAB9A (0.42) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL9865750 0.93 RAB9A (0.43) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL9866766 0.90 HRH2 (0.49) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL9866425 0.88 RAB9A (0.42) RAB9ASMN1; SMN2NPC1HPGDLMNA
SCHEMBL9865732 0.86 HPGD (0.52) RAB9ASMN1; SMN2NPC1HPGDALDH1A1
SCHEMBL9865202 0.86 HRH4 (0.43) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL9866047 0.86 HRH4 (0.43) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL11080978 0.86 HRH2 (0.47) RAB9ANPC1HRH4HRH2
SCHEMBL9867694 0.85 HRH2 (0.44) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed